Stay updated with breaking news from Myriad Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- DelveInsight's Anti-Radiation Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-radiation...
The rise in demand for anti-radiation drugs is mainly driven by several factors. These include the growing occurrence of side effects linked to cancer screening methods, heightened risks of
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) Director Daniel K. Spiegelman sold 3,788 shares of Myriad Genetics stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $22.04, for a total transaction of $83,487.52. Following the sale, the director now directly owns 36,705 shares in the company, […]
Press release - DataM Intelligence - Age Related Macular Degeneration Market 2024 Highlights on Future Development, Top Trends and Leading Players Analysis to 2031 Bayer, Novartis. - published on openPR.com
Artisan Partners Limited Partnership trimmed its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 4.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,433,377 shares of the company’s stock after selling 103,770 shares during the quarter. […]